Ashley Bailey, OD
Optometrist · Chehalis, WANPI 1760034821
Payments from drug & device makers
Across 18 payments — averaging $22.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$76
- Glaukos Corporation$70
- Bausch & Lomb Americas Inc.$61
- Amgen$46
- Sight Sciences, Inc.$41
- Rayner Intraocular Lenses Limited$28
- plus $81 from 4 others
What the payments were for
- Food & beverage$402100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $76 |
| Glaukos Corporation | 3 | $70 |
| Bausch & Lomb Americas Inc. | 3 | $61 |
| Amgen | 1 | $46 |
| Sight Sciences, Inc. | 2 | $41 |
| Rayner Intraocular Lenses Limited | 1 | $28 |
| Biotissue Holdings Inc. | 1 | $26 |
| Alcon | 1 | $21 |
| Rxsight Inc | 1 | $20 |
| Harrow Eye, LLC | 1 | $14 |
How this compares
$402 in reported general payments places this provider in the 40th percentile of 1,267 optometrist providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 173 | $8,457 |
| Ofloxacin | 127 | $2,340 |
| Ketorolac Tromethamine | 71 | $1,995 |
| Loteprednol Etabonate | 14 | $1,659 |
| Brimonidine Tartrate | 87 | $1,210 |
| Latanoprost | 89 | $682 |
| Dorzolamide Hcl | 17 | $274 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 28 | $234 |
| Timolol Maleate | 26 | $150 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Chehalis
- Brian ArvidsonChehalis$12K
- David KadingKirkland$517K
- Peter BergenskeOtis Orchards$355K
- Casey ClaypoolSpokane Valley$337K
- Charles ClaytonBellevue$195K
- Herminder BoparaiBellevue$131K
- Rajiv PatelVancouver$118K
- Alan ChousTacoma$115K
- Roya HabibiSeattle$109K
- Bryan HeitmeyerKent$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.